A Peptide in a Pill – Oral Semaglutide in the Management of Type 2 Diabetes
Raja Selvarajan,1,* Rashmi Subramanian2,* 1Department of Diabetes and Research Kaveri Healthcare, Bangalore, Karnataka, India; 2Department of Research and Development, Kaveri Healthcare, Bangalore, Karnataka, India*These authors contributed equally to this workCorrespondence:...
Main Authors: | Selvarajan R, Subramanian R |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-06-01
|
Series: | Diabetes, Metabolic Syndrome and Obesity |
Subjects: | |
Online Access: | https://www.dovepress.com/a-peptide-in-a-pill--oral-semaglutide-in-the-management-of-type-2-diab-peer-reviewed-fulltext-article-DMSO |
Similar Items
-
Glycemic treatment effect of oral semaglutide plus other antidiabetic medications: An Indian experience
by: Manoj Chawla, et al.
Published: (2022-01-01) -
Cost-effectiveness analysis of once-daily oral semaglutide versus placebo and subcutaneous glucagon-like peptide-1 receptor agonists added to insulin in patients with type 2 diabetes in China
by: Zhen Feng, et al.
Published: (2023-08-01) -
Oral Semaglutide, the First Ingestible Glucagon-Like Peptide-1 Receptor Agonist: Could It Be a Magic Bullet for Type 2 Diabetes?
by: Hwi Seung Kim, et al.
Published: (2021-09-01) -
Efficacy and safety of oral semaglutide in Russian patients with type 2 diabetes: subgroup analysis of PIONEER 1, 2, 3 trials
by: M. Sh. Shamkhalova, et al.
Published: (2022-07-01) -
The Effectiveness of GLP-1 Receptor Agonist Semaglutide on Body Composition in Elderly Obese Diabetic Patients: A Pilot Study
by: Yoshinori Ozeki, et al.
Published: (2022-09-01)